Fidelity Investments
CYT

Fidelity Investments’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Fidelity Investments’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-826,758
Closed -$2.35M – 5715
2023
Q3 		$2.35M Sell
826,758
-1,109
-0.1% -$3.06K ﹤0.01% 2247
2023
Q2 		$2.15M Sell
827,867
-1,424,464
-63% -$2.98M ﹤0.01% 2295
2023
Q1 		$4.1M Sell
2,252,331
-656,045
-23% -$1.07M ﹤0.01% 2151
2022
Q4 		$4.8M Sell
2,908,376
-577,682
-17% -$927K ﹤0.01% 2140
2022
Q3 		$6.69M Sell
3,486,058
-386,231
-10% -$1.01M ﹤0.01% 2069
2022
Q2 		$11.6M Sell
3,872,289
-628,944
-14% -$1.61M ﹤0.01% 1899
2022
Q1 		$17M Buy
4,501,233
+452,240
+11% +$2.57M ﹤0.01% 1857
2021
Q4 		$46M Sell
4,048,993
-236,666
-6% -$3.61M ﹤0.01% 1456
2021
Q3 		$75.2M Buy
4,285,659
+3,225,453
+304% +$60.3M 0.01% 1236
2021
Q2 		$22.7M Buy
+1,060,206
New +$19.9M ﹤0.01% 1801

Other funds holding CYT

BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.57B AUM 370.24% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $16.3B AUM 37.67% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return